SCHEMBL30980616

SCHEMBL30980616

CCC[C@H]1O[C@H](COC(C)=O)[C@H](OC(C)=O)[C@H](OC(C)=O)[C@H]1NC(C)=O

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ LMNA P02545 4/20 0.54
▸ KMT2A Q03164 1/20 0.54
▸ POLB P06746 2/20 0.53
▸ ALDH1A1 P00352 2/20 0.53
▸ NR3C1 P04150 1/20 0.48
▸ FYN P06241 1/20 0.48
▸ ADRA2A P08913 1/20 0.48
▸ ADORA3 P0DMS8 1/20 0.48
▸ ADRA2B P18089 1/20 0.48
▸ DRD4 P21917 1/20 0.48
▸ DRD3 P35462 1/20 0.48
▸ CA1 P00915 6/20 0.47
▸ CA2 P00918 6/20 0.47
▸ CA9 Q16790 6/20 0.47
▸ CA12 O43570 5/20 0.47
▸ CYP3A4 P08684 1/20 0.47
▸ MAPT P10636 1/20 0.47
▸ CYP2C9 P11712 1/20 0.47
▸ CYP2C19 P33261 1/20 0.47
▸ THRB P10828 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16393065 0.90 LMNA (0.54) LMNAKMT2APOLBALDH1A1NR3C1
SCHEMBL16393027 0.90 LMNA (0.54) LMNAKMT2APOLBALDH1A1NR3C1
SCHEMBL7616209 0.88 LMNA (0.53) LMNAKMT2APOLBALDH1A1NR3C1
SCHEMBL30721980 0.88 LMNA (0.45) LMNAKMT2APOLBALDH1A1NR3C1
SCHEMBL16392999 0.86 LMNA (0.56) LMNAKMT2APOLBALDH1A1NR3C1
SCHEMBL28694159 0.86 LMNA (0.53) LMNAKMT2APOLBALDH1A1NR3C1
SCHEMBL31538817 0.85 LMNA (0.56) LMNAKMT2APOLBALDH1A1NR3C1
SCHEMBL22899114 0.85 LMNA (0.50) LMNAKMT2APOLBALDH1A1NR3C1
SCHEMBL18349732 0.85 LMNA (0.50) LMNAKMT2APOLBALDH1A1NR3C1
SCHEMBL26986927 0.84 NR3C1 (0.59) NR3C1FYNADRA2AADORA3ADRA2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4651902-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES Lycia Therapeutics, Inc. (US) 2025-11-26 — — EP disclosed
WO-2024155747-A2 ASGPR BINDING COMPOUNDS AND CONJUGATES LYCIA THERAPEUTICS, INC. (US) 2024-07-25 — — WO disclosed
Send feedback